United Services Automobile Association’s Intellia Therapeutics NTLA Stock Holding History

United Services Automobile Association’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-24,958	Closed	-$714K	–	2280
2018 Q3	$714K	Sell	24,958 -13,527	-35%	-$394K	﹤0.01%	1515
2018 Q2	$1.05M	Sell	38,485 -403	-1%	-$9.76K	﹤0.01%	1339
2018 Q1	$820K	Sell	38,888 -2,270	-6%	-$55.8K	﹤0.01%	1480
2017 Q4	$791K	Sell	41,158 -51,542	-56%	-$1.19M	﹤0.01%	1280
2017 Q3	$2.3M	Hold	92,700	–	–	0.01%	1023
2017 Q2	$1.48M	Buy	+92,700	New	+$1.3M	﹤0.01%	1106

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OTPPB

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

United Services Automobile Association's NTLA Position: Q4 2018 in Review

United Services Automobile Association sold out of Intellia Therapeutics (NTLA) in Q4 2018, closing a stake of 24,958 shares — an estimated $714K sold.

United Services Automobile Association first reported a position in NTLA in Q2 2017 and held it in 6 quarters. The position peaked at $2.3M in Q3 2017. 141 funds tracked by Wall St. Rank hold NTLA as of Q4 2018.

United Services Automobile Association reported no remaining Intellia Therapeutics position as of Q4 2018 after selling out during the quarter.
United Services Automobile Association sold 24,958 Intellia Therapeutics shares in Q4 2018, an estimated $714K.
United Services Automobile Association first reported a position in Intellia Therapeutics in Q2 2017 and held it in 6 quarters.
United Services Automobile Association's Intellia Therapeutics position peaked at $2.3M in Q3 2017.
141 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q4 2018.

Based on United Services Automobile Association's 13F filing for Q4 2018, filed 13 Feb 2019.